The FDA approves the use of Medtronic's CoreValve transcatheter aortic valve implant in so-called 'valve-in-valve' replacement procedures.
Regulators in Japan approve Medtronic's CoreValve transcatheter aortic valve implant.
Medtronic (NYSE:MDT) today said it won approval in Japan for its CoreValve replacement heart valve.
Here's a look at some of the top legal news stories for medical device companies this week: Osprey Medical fishes up $11m private placement; OrthoSensor closes $19m Series C round; Diabetes: Medtronic joins $44m round for Semma Therapeutics
Medtronic says it bought Sophono, which makes magnetic hearing aid implants, for an undisclosed amount.
Medtronic (NYSE:MDT) today said it closed a buyout of hearing aid maker Sophono for an undisclosed amount and plans to integrate it into its ear, nose & throat business.
Medtronic gets in on a $44 million Series A round for Semma Therapeutics, which is developing a cell therapy-device treatment for Type 1 diabetes.
Here's a look at some of the top regulatory stories for medical device companies this week: Boston Scientific wins CE Mark, FDA nod for smaller 'leadless' ICD; FDA approves Biotronik's Eluna MRI-safe pacemaker; PAD: Medtronic wins expanded FDA nod for Protégé GPS stent; Australian PE shop acquires Simplify Medical
Here's a look at some of the top legal news stories for medical device companies this week: Diabetes: Medtronic gets in on $17m Series B for Glooko; Pegasus Therapeutics looks to Indiegogo for pediatric aneurysm device; Svelte Medical adds $16m for wrist-delivered stent